Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults

被引:14
作者
Reid, Michael [1 ]
Ma, Yifei [1 ]
Scherzer, Rebecca [1 ,2 ]
Price, Jennifer C. [1 ]
French, Audrey L. [3 ,4 ]
Plankey, Michael W. [5 ]
Grunfeld, Carl [1 ,2 ]
Tien, Phyllis C. [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[2] Dept Veteran Affairs Med Ctr, Med Serv, San Francisco, CA USA
[3] Stroger Hosp, Dept Med, Chicago, IL USA
[4] Rush Univ, Chicago, IL 60612 USA
[5] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA
关键词
hepatitis C virus; HIV; inflammation; insulin resistance; microbial translocation; monocyte activation; WOMENS INTERAGENCY HIV; ANTIRETROVIRAL THERAPY EXPOSURE; HOMEOSTASIS MODEL ASSESSMENT; TYPE-2; DIABETES-MELLITUS; GLUCOSE CLAMP TECHNIQUE; SOLUBLE CD163; MICROBIAL TRANSLOCATION; IMMUNE ACTIVATION; RISK; OBESITY;
D O I
10.1097/QAD.0000000000001345
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: HIV/hepatitis C virus (HCV) coinfection is associated with insulin resistance, but the mechanism is unclear. We hypothesized that intestinal epithelial damage and the consequent monocyte/macrophage activation and inflammation explain this perturbation. Design: Cross-sectional study of 519 adults (220 HIV+/HCV-; 64 HIV-/HCV+; 89 HIV+/HCV+; 146 HIV-/HCV-). Methods: We used multivariable linear regression to evaluate associations of HIV and HCV with the homeostasis model assessment of insulin resistance (HOMA-IR) and if intestinal fatty (FA) acid binding protein (I-FABP, a marker of gut epithelial integrity), soluble CD14 (sCD14) and soluble CD163 (sCD163) (markers of monocyte/macrophage activation), and IL-6 (an inflammatory cytokine) mediated this association. Results: HIV+/HCV+ and HIV-/HCV+ had greater demographic-adjusted HOMA-IR [mean (95% confidence interval (CI)): 1.96 (1.51, 2.54) and 1.65 (1.22, 2.24)] than HIV+/HCV- and HIV-/HCV- [1.41 (1.18, 1.67) and 1.44 (1.17, 1.75), respectively]. After additional adjustment for lifestyle and metabolic factors, HIV+/HCV+ remained associated with 36% (95% CI: 4, 80%) greater HOMA-IR relative to HIV+/HCV+, whereas HIV-/HCV+ and HIV+/HCV- had smaller differences. Adjustment for sCD163 substantially attenuated the difference between HIV+/HCV+ and HIV-/HCV+; adjustment for I-FABP, sCD14, and IL-6 had little effect. Higher sCD163 was independently associated with 19% (95% CI: 7, 33%), 26% (95% CI: 15, 39%), 25% (95% CI: 14, 37%), and 23% (95% CI: 11, 36%) greater HOMA-IR in HIV+/HCV+, HIV-/HCV+, HIV+/HCV-, and HIV-/HCV- (all estimates per doubling of sCD163). I-FABP, sCD14, and IL-6 were not associated with HOMA-IR. Conclusion: HIV/HCV coinfection is associated with greater HOMA-IR, even after controlling for demographic, lifestyle, and metabolic factors. sCD163, which appears independent of intestinal epithelial damage and inflammation, partly explains this association. Our findings that the association of sCD163 with HOMA-IR occurred even in the absence of HIV and HCV, indicate that viral and nonviral factors affect sCD163 levels. Its role in insulin resistance needs elucidation. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
引用
收藏
页码:385 / 393
页数:9
相关论文
共 50 条
  • [21] Current guidelines and prioritizing treatment of hepatitis C virus in HIV-infected patients
    Feeney, Eoin R.
    Chung, Raymond T.
    Yazdanpanah, Yazdan
    CURRENT OPINION IN HIV AND AIDS, 2015, 10 (05) : 323 - 329
  • [22] Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?
    John, M
    Flexman, J
    French, MAH
    AIDS, 1998, 12 (17) : 2289 - 2293
  • [23] Predictors of insulin resistance among Hispanic adults infected with or at risk of infection with the human immunodeficiency virus and hepatitis C virus
    Castaneda-Sceppa, C.
    Bermudez, O. I.
    Wanke, C.
    Forrester, J. E.
    JOURNAL OF VIRAL HEPATITIS, 2008, 15 (12) : 878 - 887
  • [24] High Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children
    Benki-Nugent, Sarah F.
    Martopullo, Ira
    Laboso, Tony
    Tamasha, Nancy
    Wamalwa, Dalton C.
    Tapia, Kenneth
    Langat, Agnes
    Maleche-Obimbo, Elizabeth
    Marra, Christina M.
    Bangirana, Paul
    Boivin, Michael J.
    John-Stewart, Grace C.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 81 (01) : 102 - 109
  • [25] Differential Expression of CD163 on Monocyte Subsets in Healthy and HIV-1 Infected Individuals
    Tippett, Emma
    Cheng, Wan-Jung
    Westhorpe, Clare
    Cameron, Paul U.
    Brew, Bruce J.
    Lewin, Sharon R.
    Jaworowski, Anthony
    Crowe, Suzanne M.
    PLOS ONE, 2011, 6 (05):
  • [26] Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people
    Polgreen, P
    Flutz, SL
    Justice, AC
    Wagner, JH
    Diekema, DJ
    Rabeneck, L
    Weissman, S
    Stapleton, JT
    HIV MEDICINE, 2004, 5 (03) : 144 - 150
  • [27] The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients
    Dultz, G.
    Gerber, L.
    Zeuzem, S.
    Sarrazin, C.
    Waidmann, O.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (04) : 267 - 273
  • [28] Prevalence of cryoglobulins and hepatitis C virus infection in HIV-infected patients
    Cohen, P
    Roulot, D
    Ferriere, F
    Nguyen, QT
    Lortholary, O
    Jarrousse, B
    Deny, P
    Coste, T
    Robineau, M
    Guillevin, L
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1997, 15 (05) : 523 - 527
  • [29] Naringenin ameliorates insulin resistance by modulating endoplasmic reticulum stress in hepatitis C virus-infected liver
    Jia, Benli
    Wang, Yong
    Yu, Gang
    Cheng, Yunsheng
    Yang, Chuang
    Cao, Feng
    He, Yan
    Cao, Pengwei
    Meng, Xiangling
    Yu, Dongsheng
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 115
  • [30] Amino acid metabolism dysregulation associated with inflammation and insulin resistance in HIV-infected individuals with metabolic disorders
    Jing Zhang
    Yanfang Chen
    Mingli Wang
    Liuting Zhong
    Linghua Li
    Zhongwen Yuan
    Shangrong Zou
    Amino Acids, 2023, 55 : 1545 - 1555